HOUSTON--(BUSINESS WIRE)--March 28, 2005--Applied Veterinary Genomics, Inc. ("AVGI") today announced that its long delay in finalizing its research on equine lameness has been successfully resolved by a Harris County jury. That delay resulted from the refusal of CytoGenix, Inc.(OTCBB:CYGX) to honor its license agreements. These dishonored licenses granted AVGI the right to use CytoGenix's patented ssDNA vector in both equines and crustaceans. The licenses, originally granted by CytoGenix to William B. Waldroff, were subsequently acquired by AVGI from Waldroff. In the recent decision, the 11th Judicial District Court of Harris County, Texas, entered its judgement confirming the jury's swift finding of multiple breaches of contract by CytoGenix, and ordering CytoGenix to provide its patented ssDNA vector expression in accordance with the licenses. The court also entered permanent injunctions against certain future CytoGenix conduct and ordered CytoGenix to pay both AVGI and Waldroff their respective attorney fees and all court costs.
